Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial

Overview of attention for article published in Journals of Gerontology Series A: Biological Sciences & Medical Sciences, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet

twitter: 8 X users

Readers on

mendeley: 57 Mendeley

So far, Altmetric has seen 78 X posts from 8 X users, with an upper bound of 68,700 followers.

Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial https://t.co/elIVEbaNGK

Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial https://t.co/LPSzrh5ybC

Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial https://t.co/heqkrMgmSW

Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial https://t.co/KUtIguUsK7

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 74 additional X posts.